Delivery Order SPE2DB22D2206-SPE2DB24FKC91
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$34K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,024.40 firm fixed-price delivery order is for the provision of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,097,643 units of REMICADE 100 mg vials. The $3,179.58 contract has a period of performance through March 28, 2024 and does not have a set-aside designation. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,024.40, is for the supply of 4,568,093,049 units of Remicade 100 mg vials. The award has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,510.45, is for the delivery of REMICADE 100 MG VIALS, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 8, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,503.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566947340 - REMICADE 100 MG VIALS, and has an ultimate completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,012.20, is for the delivery of REMICADE 100 MG VIALS medical supplies. The contract has an ultimate completion date of May 21, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,857.41 firm fixed-price delivery order is for the supply of REMICADE 100 MG VIALS, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of May 28, 2025. Amerisourcebergen Drug Corp is also the holder of a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $39,172.04 and is for the delivery of REMICADE 100 MG VIALS. The contract is a firm fixed-price delivery order with a period of performance through July 9, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,058.97 firm-fixed-price delivery order is for the supply of REMICADE 100 mg vials, a specialty medication. The contract has an ultimate completion date of May 23, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,887.20 firm fixed price delivery order is for the supply of 100 mg REMICADE vials. The contract has an ultimate completion date of August 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...